Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis

NCT03839680 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.

NCT NCT03839680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03839680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2018
Completion date
April 15, 2019
Enrollment
60 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis